Interestingly, the NF-κB nuclear transport inhibitor SN-50 has a dominant anti-inflammatory effect and alleviates the neuroinflammation-mediated neurotoxicity induced by DJ-1 deficiency combined with LPS treatment. The gene discussed is PARK7; the disease is hyperinsulinemic hypoglycemia, familial, 4.